Invacare Corporation (NYSE:IVC) saw an upside of 6.07% to close Tuesday at $4.72 after adding $0.27 on the day. The 5-day average trading volume is 772,600 shares of the company’s common stock. It has gained $4.80 in the past week. An average of 812,805 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 755,940.
IVC’s 1-month performance is -27.27% or -$0.76 on its low of $4.08 reached on 10/06/21. The company’s shares have touched a 52-week low of $4.08 and high of $10.94, with the stock’s rally to the 52-week high happening on 01/27/21. YTD, IVC has lost -47.26% or -$4.23. However, the current price is down -56.86%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
On Aug 06, 68 days have gone by since the last insider trading activity for Invacare Corporation (IVC). Shah Baiju R. (Director) most recently sold 6,948 shares at $8.50 per share on Aug 06. This transaction cost the insider $59,058. Sr. VP and General Counsel, LaPlaca Anthony, sold 1,400 shares at a price of $7.77 on Jul 15. Then, on Jan 27, Sr. VP and General Counsel LaPlaca Anthony sold 100 shares at a price of $10.95 per share. This transaction amounted to $1,095.
Invacare Corporation (IVC) has a trailing price-to-earnings (P/E) ratio of 26.30 for the broader industry and 32.19 for the sector.IVC stock has a beta of 1.02. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 0.18 while the price-to-book (PB) in the most recent quarter is 0.59.
Invacare Corporation’s quick ratio for the period ended June 29 was 1.00, with the current ratio over the same period at 1.60 meaning that IVC stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 1.31, while the total debt to equity was 1.37. In terms of profitability, the gross margin trailing 12 months is 28.10%. The trailing 12-month EBITDA margin is 3.64% while for the period ending June 29; Invacare Corporation’s operating margin was -3.90%. The firm’s gross profit as reported stood at $245.25 million against revenue of $850.69 million.
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Analysts expected IVC to announce -$0.23 per share in earnings in its latest quarter, but it posted -$0.28, representing a -21.70% surprise. EBITDA for the quarter stood at more than $2.0 million. IVC stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 692.96 million, with total debt at $398.29 million. Shareholders hold equity totaling $35.01 million
Let’s look briefly at Invacare Corporation (IVC) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 40.99% to suggest the stock is trending Neutral, with historical volatility in this time period at 68.88%.
The stock’s 5-day moving average is $4.49, reflecting a +10.02% or $0.43 change from its current price. IVC is currently trading -20.27% above its 20-day SMA, -41.87% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by -32.76% and -44.86% respectively.
Stochastic %K and %D was 29.36% and 23.51% and the average true range (ATR) pointed at 0.43. The RSI (14) points at 37.21%, while the 14-day stochastic is at 36.36% with the period’s ATR at 0.46. The stock’s 9-day MACD Oscillator is pointing at 0.06 and -0.18 on the 14-day charts.
In the most recent analyst report for Invacare Corporation (NYSE: IVC), Oppenheimer launched coverage with an Outperform rating. Analysts offering their rating for IVC stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate IVC as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.
What is IVC’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $8.00 and a high of $11.00, with their median price target at $10.00. Looking at these predictions, the average price target given by analysts is for Invacare Corporation (IVC) stock is $9.67.